Abstract

PIP: Efficacy of Alpagelle, a vaginal contraceptive jelly containing benzalkonium chlorohydrate, was tested on 34 women who had been using it for some. The testing was conducted using fresh human spermatozoa, and measuring the penetration into the cervical mucus 24 hours after instillation of 2 ml. of Alpagelle. Maximum penetration of spermatozoa before immobilization and death was 2/10 mm., while it is 2mm. a minute under normal conditions. Alpagelle has no contraindications, and only 1 application every 24 hours will provide contraceptive protection; such method could be ideal for women presenting temporary or permanent contraindications to the IUD, or to the pill, or to those who wish to opt for a method free of side effects.